Quick Take
scPharmaceuticals (SCPH) has taken two drugs that are generically available and very widely utilized in IV form and has reformulated them allowing for a more convenient subcutaneous route of administration. The innovation the company is offering is that the reformulated drugs have a pH that allows for delivery under the skin at home without an IV line. This seemingly simple modification provides a value proposition for payers that is very compelling. Each of the two drugs in the pipeline is very widely prescribed and according to the company has a market